Filing Details
- Accession Number:
- 0001209191-23-058710
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-14 20:59:42
- Reporting Period:
- 2023-12-13
- Accepted Time:
- 2023-12-14 20:59:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1231457 | Genelux Corp | GNLX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1324991 | L James Tyree | C/O Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village CA 91361 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-12-13 | 5,653 | $12.91 | 6,807 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-12-13 | 3,347 | $13.73 | 3,460 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The weighted average sale price for the transaction reported was $12.9145, and the range of prices were between $12.29 and $13.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $13.7327, and the range of prices were between $13.33 and $14.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.